Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic CancerThomas B. Karasic, Peter J. O’Dwyer, Arturo Loaiza‐Bonilla et al.|JAMA Oncology|2019Cited by 289
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinomaAna De Jesus‐Acosta, Daniel A. Laheru|British Journal of Cancer|2019Cited by 163